Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma

PURPOSE: Oligoprogression, defined as limited sites of progression on systemic therapy, in patients with metastatic renal cell carcinoma (mRCC) is not uncommon, possibly because of inter- and intratumoral heterogeneity. We evaluated the effect of stereotactic ablative radiation therapy (SAbR) for lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoenhals, Jonathan E., Mohamad, Osama, Christie, Alana, Zhang, Yuanyuan, Li, Daniel, Singla, Nirmish, Bowman, Isaac, Arafat, Waddah, Hammers, Hans, Courtney, Kevin, Cole, Suzanne, Bagrodia, Aditya, Margulis, Vitaly, Desai, Neil, Garant, Aurelie, Choy, Hak, Timmerman, Robert, Brugarolas, James, Hannan, Raquibul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498727/
https://www.ncbi.nlm.nih.gov/pubmed/34646963
http://dx.doi.org/10.1016/j.adro.2021.100692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498727/
https://www.ncbi.nlm.nih.gov/pubmed/34646963
http://dx.doi.org/10.1016/j.adro.2021.100692

Ejemplares similares